Go Pro

State Street Corp Has $196.66 Million Stake in Cabot Corporation $CBT

Cabot logo with Materials background
Image from MarketBeat Media, LLC.

Key Points

  • State Street increased its Cabot stake by 6.8% in the second quarter, holding 2.17 million shares worth approximately $196.7 million, or 4.19% of the company. Institutional investors collectively own 93.18% of Cabot.
  • Cabot reported quarterly EPS of $1.67, slightly exceeding estimates, while revenue rose 6.4% year over year to $982 million. The company reaffirmed fiscal 2026 EPS guidance of $6.15–$6.45.
  • Cabot shares opened at $78.83, below the analyst consensus target of $89.00. Analysts maintain a consensus “Hold” rating, while CEO Sean Keohane sold $11.5 million worth of shares and the company continues paying a $0.4725 quarterly dividend.
  • MarketBeat previews top five stocks to own in October.

State Street Corp raised its stake in shares of Cabot Corporation (NYSE:CBT - Free Report) by 6.8% during the 2nd quarter, according to the company in its most recent filing with the SEC. The firm owned 2,165,434 shares of the specialty chemicals company's stock after purchasing an additional 138,098 shares during the quarter. State Street Corp owned 4.19% of Cabot worth $196,665,000 as of its most recent filing with the SEC.

Several other hedge funds have also made changes to their positions in the stock. Rothschild Investment LLC increased its stake in Cabot by 170.4% during the fourth quarter. Rothschild Investment LLC now owns 411 shares of the specialty chemicals company's stock valued at $27,000 after acquiring an additional 259 shares during the period. Northwestern Mutual Wealth Management Co. bought a new stake in shares of Cabot during the second quarter valued at approximately $33,000. Caitong International Asset Management Co. Ltd increased its position in shares of Cabot by 76.8% during the fourth quarter. Caitong International Asset Management Co. Ltd now owns 944 shares of the specialty chemicals company's stock valued at $63,000 after purchasing an additional 410 shares during the period. Hantz Financial Services Inc. raised its stake in shares of Cabot by 131.0% in the fourth quarter. Hantz Financial Services Inc. now owns 991 shares of the specialty chemicals company's stock valued at $66,000 after purchasing an additional 562 shares in the last quarter. Finally, Rockefeller Capital Management L.P. raised its stake in shares of Cabot by 115.3% in the fourth quarter. Rockefeller Capital Management L.P. now owns 1,152 shares of the specialty chemicals company's stock valued at $76,000 after purchasing an additional 617 shares in the last quarter. Institutional investors own 93.18% of the company's stock.

Insider Buying and Selling

In other news, CEO Sean Keohane sold 134,895 shares of the firm's stock in a transaction on Friday, August 28th. The stock was sold at an average price of $85.00, for a total value of $11,466,075.00. Following the completion of the sale, the chief executive officer directly owned 404,134 shares in the company, valued at approximately $34,351,390. This trade represents a 25.03% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Insiders sold a total of 229,597 shares of company stock valued at $19,646,746 over the last quarter. 3.08% of the stock is currently owned by insiders.

Cabot Stock Down 0.8%

Shares of NYSE:CBT opened at $78.83 on Thursday. The company's fifty day moving average is $84.51 and its 200-day moving average is $81.79. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.97 and a current ratio of 1.47. Cabot Corporation has a 52 week low of $58.33 and a 52 week high of $94.53. The company has a market capitalization of $4.07 billion, a PE ratio of 22.20, a P/E/G ratio of 10.43 and a beta of 0.83.

Cabot (NYSE:CBT - Get Free Report) last announced its quarterly earnings results on Monday, August 3rd. The specialty chemicals company reported $1.67 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.66 by $0.01. The firm had revenue of $982.00 million during the quarter, compared to the consensus estimate of $943.16 million. Cabot had a net margin of 5.23% and a return on equity of 20.29%. The firm's quarterly revenue was up 6.4% on a year-over-year basis. During the same period last year, the firm posted $1.90 EPS. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. Equities research analysts predict that Cabot Corporation will post 6.35 earnings per share for the current fiscal year.

Cabot Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 11th. Shareholders of record on Friday, August 28th were given a $0.4725 dividend. The ex-dividend date was Friday, August 28th. This represents a $1.89 annualized dividend and a yield of 2.4%. Cabot's payout ratio is presently 53.24%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on CBT shares. Mizuho lifted their price target on shares of Cabot from $80.00 to $90.00 and gave the stock a "neutral" rating in a research note on Thursday, June 25th. UBS Group dropped their price objective on shares of Cabot from $97.00 to $92.00 and set a "neutral" rating for the company in a research note on Wednesday, August 5th. Weiss Ratings reaffirmed a "hold (c)" rating on shares of Cabot in a report on Friday, August 21st. JPMorgan Chase & Co. lifted their target price on shares of Cabot from $70.00 to $78.00 and gave the company an "underweight" rating in a research report on Friday, August 7th. Finally, Wall Street Zen raised shares of Cabot from a "hold" rating to a "buy" rating in a research report on Sunday, August 9th. Two investment analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company has a consensus rating of "Hold" and a consensus target price of $89.00.

View Our Latest Report on CBT

About Cabot

(Free Report)

Cabot Corporation NYSE: CBT is a global specialty chemicals and performance materials company. Its products are used by manufacturers in transportation, infrastructure, energy, electronics, consumer goods, and other industrial markets.

Cabot's Reinforcement Materials business produces carbon black and other materials used to reinforce tires, automotive components, industrial rubber products, and plastics. Its Performance Chemicals business supplies specialty carbon blacks, fumed metal oxides, inkjet colorants, conductive compounds, masterbatch products, and related materials used to modify the color, conductivity, strength, durability, and processing characteristics of finished products.

Founded in 1882, Cabot operates research, manufacturing, and commercial facilities serving customers in North America, South America, Europe, Asia, and other international markets.

Recommended Stories

Institutional Ownership by Quarter for Cabot (NYSE:CBT)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Cabot Right Now?

Before you consider Cabot, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cabot wasn't on the list.

While Cabot currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines